{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:34:37Z","timestamp":1780072477916,"version":"3.54.0"},"reference-count":23,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,1,6]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Sideroblastic anaemia is a rare condition. We report a unique case of concomitant sideroblastic anaemia in a patient with sickle cell disease with long-standing blood transfusion history. Due to a low prevalence of sideroblastic anaemia, the diagnosis of sideroblastic anaemia is often difficult, especially when coexisting with common types of anaemia, including sickle cell disease. This case highlights the detrimental effects of anchoring bias. Rare causes of refractory anaemia should be considered in patients with haemoglobin disorders as the therapeutic approaches for these conditions are different. High suspicion on the part of the clinician and low threshold for workup of anaemia often aids in the diagnosis of coexisting conditions such as sideroblastic anaemia. Early diagnosis and treatment of sideroblastic anaemia improves patient outcomes and prevents long-term complications.<\/jats:p>","DOI":"10.1136\/bcr-2021-246623","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T12:02:11Z","timestamp":1644321731000},"page":"e246623","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Sideroblastic anaemia in a patient with sickle cell disease"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-0219","authenticated-orcid":false,"given":"Nikitha","family":"Vobugari","sequence":"first","affiliation":[{"name":"Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana Miriam","family":"Schlam-Camhi","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, Tufts Medical Center, Boston, Massachusetts, USA"},{"name":"Hematology\/Oncology, MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy Patricia","family":"Smith","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"2025082712415094000_15.2.e246623.1","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/143594","article-title":"Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies","volume":"2012","author":"Pace","year":"2012","journal-title":"Anemia"},{"key":"2025082712415094000_15.2.e246623.2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MLR.0000000000000143","article-title":"National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008","volume":"52","author":"Okam","year":"2014","journal-title":"Med Care"},{"key":"2025082712415094000_15.2.e246623.3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2025082712415094000_15.2.e246623.4","unstructured":"Ashorobi D , Chhabra A . Sideroblastic anemia. In: StatPearls [Internet]. StatPearls Publishing, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538287\/"},{"key":"2025082712415094000_15.2.e246623.5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrrev.2018.06.003","article-title":"Rare anemias due to genetic iron metabolism defects","volume":"777","author":"Brissot","year":"2018","journal-title":"Mutat Res Rev Mutat Res"},{"key":"2025082712415094000_15.2.e246623.6","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12217"},{"key":"2025082712415094000_15.2.e246623.7","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2368-0"},{"key":"2025082712415094000_15.2.e246623.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2025082712415094000_15.2.e246623.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2009.07.001"},{"key":"2025082712415094000_15.2.e246623.10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.044628"},{"key":"2025082712415094000_15.2.e246623.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-815951"},{"key":"2025082712415094000_15.2.e246623.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.03.010"},{"key":"2025082712415094000_15.2.e246623.13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood.V58.5.963.963","article-title":"The diagnosis of iron deficiency anemia in sickle cell disease","volume":"58","author":"Vichinsky","year":"1981","journal-title":"Blood"},{"key":"2025082712415094000_15.2.e246623.14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V67.1.46.46","article-title":"Sickle cell anemia patients have low erythropoietin levels for their degree of anemia","volume":"67","author":"Sherwood","year":"1986","journal-title":"Blood"},{"key":"2025082712415094000_15.2.e246623.15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4274\/tjh.2016.0090","article-title":"Megaloblastic anemia with ring sideroblasts is not always myelodysplastic syndrome","volume":"33","author":"Narang","year":"2016","journal-title":"Tjh"},{"key":"2025082712415094000_15.2.e246623.16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/JBM.S232644","article-title":"Understanding sideroblastic anemia: an overview of genetics, epidemiology, pathophysiology and current therapeutic options","volume":"11","author":"Abu-Zeinah","year":"2020","journal-title":"J Blood Med"},{"key":"2025082712415094000_15.2.e246623.17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22244"},{"key":"2025082712415094000_15.2.e246623.18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095513"},{"key":"2025082712415094000_15.2.e246623.19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/ccr3.1667","article-title":"Reduced-toxicity allogeneic hematopoietic stem cell transplantation in congenital sideroblastic anemia","volume":"6","author":"Kim","year":"2018","journal-title":"Clin Case Rep"},{"key":"2025082712415094000_15.2.e246623.20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1365-2141.2001.02855.x","article-title":"Congenital sideroblastic anaemia successfully treated using allogeneic stem cell transplantation","volume":"113","author":"Ayas","year":"2001","journal-title":"Br J Haematol"},{"key":"2025082712415094000_15.2.e246623.21","doi-asserted-by":"publisher","DOI":"10.1177\/2040620713483063"},{"key":"2025082712415094000_15.2.e246623.22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bcmd.2017.08.014","article-title":"Curative approaches for sickle cell disease: a review of allogeneic and autologous strategies","volume":"67","author":"Bauer","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"2025082712415094000_15.2.e246623.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-016-0377-1"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-246623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:41:57Z","timestamp":1756323717000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-246623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,8]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bcr-2021-246623"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-246623","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}